BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 123832)

  • 21. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
    Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
    Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biochemical differentiation of mucopolysaccharidoses].
    Spranger J; Wiedemann HR
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):421-3. PubMed ID: 4257110
    [No Abstract]   [Full Text] [Related]  

  • 23. Hurler's, Hunter's and Morquio's syndromes. A biochemical study in the light of current views of the underlying defects.
    Dean MF; Muir H; Ewins RJ
    Biochem J; 1971 Aug; 123(5):883-94. PubMed ID: 4256532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical rotatory dispersion of mucopolysaccharides. IV. Optical rotatory dispersion and circular dichroism of glycosaminoglycans and heparan sulfate fractions from the urine of patients with mucopolysaccharidosis (Hurler syndrome).
    Stone AL; Constantopoulos G; Sotsky SM; Dekaban A
    Biochim Biophys Acta; 1970 Oct; 222(1):79-89. PubMed ID: 4248803
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the composition of urinary glycosaminoglycans and oligosaccharides in patients with mucopolysaccharidoses who were receiving fibroblast transplants.
    Purkiss P; Gibbs DA; Watts RW
    Clin Chim Acta; 1983 Jun; 131(1-2):109-21. PubMed ID: 6411385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
    Satake S; Ototani N; Isemura M; Yosizawa Z
    Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reliable spot test for mucopolysaccharidoses.
    Berman ER; Vered J; Bach G
    Clin Chem; 1971 Sep; 17(9):886-90. PubMed ID: 4255193
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation and characterization of peptidoglycans in urine from patients with mucopolysaccharidoses.
    Tanaka Y; Takazono I
    Int J Biochem; 1984; 16(5):435-46. PubMed ID: 6233194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of glycosaminoglycans composition in the urine of children in reference to the clinical picture of mucopolysaccharidoses.
    Gadowska M; Dawydzik B
    Mater Med Pol; 1983; 15(1-2):24-30. PubMed ID: 6443627
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluorometric measurement of urinary alpha-L-iduronidase activity.
    Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
    J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of acid mucopolysaccharides by gas chromatographic analysis of component sugars after chemical depolymerization.
    O'Brien JF; Gerritsen T; Helmuth AC
    Anal Biochem; 1973 Dec; 56(2):465-79. PubMed ID: 4271847
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mucopolysaccharidoses. I. The clinical and radiological aspects of the 6 classical mucopolysaccharidoses].
    Bulgarelli R; Romano C
    Minerva Pediatr; 1972 Sep; 24(33):1471-578. PubMed ID: 4263584
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of genetic mucopolysaccharidoses: electrophoretic and enzymatic characterization of urinary glycosaminoglycans.
    Taniguchi N; Koizumi S; Masaki K; Kobayashi Y
    Biochem Med; 1975 Nov; 14(3):241-9. PubMed ID: 131549
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation of mucopolysaccharidoses by analyses of the excreted sulfated mucopolysaccharides.
    Cohen DM; MourĂ£o PA; Dietrich CP
    Clin Chim Acta; 1977 Nov; 80(3):555-62. PubMed ID: 144036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobilization of glycosaminoglycans by plasma infusion in mucopolysaccharidosis type 3--two types of response.
    Dean MF; Muir H; Benson PF
    Nat New Biol; 1973 May; 243(126):143-6. PubMed ID: 4268900
    [No Abstract]   [Full Text] [Related]  

  • 37. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
    Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
    Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic acid mucopolysaccharides in the mucopolysaccharidoses type I, II and 3.
    Gordon BA; Haust MD
    Clin Biochem; 1971 Oct; 4(3):147-55. PubMed ID: 4259199
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of disorders in patients with corneal clouding, normal intellect, and mucopolysaccharidosis.
    Constantopoulos G; Dekabian AS; Scheie HG
    Am J Ophthalmol; 1971 Dec; 72(6):1106-17. PubMed ID: 4256845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.